Brief: Neximmune Posts Q4 Loss Of $0.65 Per Share

Neximmune

28/03/2023 23:32

March 28 (Reuters) - Neximmune Inc  NEXI.O :
    * NEXIMMUNE REPORTS FOURTH QUARTER AND FULL YEAR 2022
FINANCIAL
RESULTS AND PROVIDES BUSINESS UPDATES
    * NEXIMMUNE INC- HAS INITIATED PRE-IND DISCUSSIONS WITH FDA
FOR
ITS FIRST AIM INJ INDICATION
    * NEXIMMUNE INC- CASH, CASH EQUIVALENTS AND MARKETABLE
SECURITIES
FOR COMPANY AS OF DECEMBER 31, 2022 WERE $34.6 MILLION
    * NEXIMMUNE INC - QTRLY DILUTED GAAP LOSS PER SHARE OF $0.65

Source text for Eikon:  ID:nGNX6MdDv9 
Further company coverage:  NEXI.O 

 ((Reuters.Briefs@thomsonreuters.com;))